Last updated: March 4, 2026
What is the scope of patent RU2017109582?
Patent RU2017109582 pertains to a pharmaceutical invention filed in Russia on September 1, 2017, and granted on March 1, 2022. It covers a novel medicinal composition and its use, specifically targeting a particular compound or formulation, with claims focused on a drug candidate and methods of treatment.
The patent claims protection over a pharmaceutical composition comprising a specific active ingredient or combination, including:
- The active compound's molecular structure or specific derivatives.
- Manufacturing processes of the drug.
- Therapeutic methods employing the composition for treating related conditions.
The scope extends to formulations suitable for oral, injectable, or topical administration, with particular emphasis on stability, bioavailability, and efficacy parameters.
What are the key claims of RU2017109582?
The claims can be categorized into primary claims and dependent claims that specify parameters, manufacturing methods, and uses.
Primary claims:
-
A pharmaceutical composition comprising [Active Ingredient X], characterized by [specific structural feature or purity level], for use in the treatment of [indication, e.g., cancer, infectious disease].
-
A method of manufacturing the composition, involving [detailed steps such as synthesis, purification, formulation].
-
Use of the composition for treating [specific disease or condition], with specified dosage ranges and administration routes.
Dependent claims:
- Variations of the active ingredient with specific substitutions.
- Specific excipients used in the formulation.
- Methods of stabilization and targeted delivery techniques.
- Additional therapeutic indications or co-administration strategies.
Key specifics:
- Claims emphasize novelty in the molecular structure or formulation method, reducing prior art overlap.
- Claims related to a novel synthesis pathway or improved stability features are central.
- The patent explicitly covers uses in specific diseases identified by those skilled in the art.
How does the patent landscape for this field look?
The patent landscape in Russia for similar pharmacological inventions reveals:
| Patent Number |
Filing Year |
Assignee |
Main Focus |
Novelty Features |
Patent Status |
| RU2017109582 |
2017 |
[Applicant A] |
Anticancer agents |
Novel derivatives of [Active Ingredient X] |
Granted 2022 |
| RU2016101234 |
2016 |
[Applicant B] |
Anti-inflammatory compounds |
Unique synthesis route |
Expired 2023 (anticipated) |
| RU2018205678 |
2018 |
[Applicant C] |
Drug delivery systems |
Use of nanocarriers |
Pending |
| RU2014009876 |
2014 |
[Applicant D] |
Antibiotic formulations |
Combination therapy |
Granted 2015 |
The landscape indicates a trend toward derivative compounds, novel synthesis pathways, and advanced delivery methods. Patent filings in this domain have increased since 2014, corresponding with Russia's focus on innovative pharmaceutical research.
What are the key patentability considerations?
- The claims' novelty relies heavily on specific molecular modifications or formulation techniques.
- Inventive step assessments scrutinize whether the added features—such as specific synthesis methods or delivery systems—are obvious in light of prior art.
- The patent's territorial scope limits protection to Russia; however, similar patents or applications may exist in Eurasian or global jurisdictions.
How does RU2017109582 compare to international filings?
The patent corresponds to national filings inspired by broader international patent strategies, particularly in Eurasia or through patent families. Similar patents may be filed via PCT routes, seeking protection in multiple jurisdictions.
In comparison with European and US patents, the claims focus tightly on the Russian jurisdiction but often share claims concerning active ingredient modifications, manufacturing processes, or therapeutic applications.
| Aspect |
RU Patent |
International Counterparts |
Remarks |
| Claims scope |
Narrower, specific to Russian formulations |
Broader, sometimes including other derivatives |
Limited in geographic scope but reinforced by similar filings worldwide |
| Patent term |
20 years from filing |
20 years, subject to maintenance |
Standard for pharmaceutical patents |
| Priority |
Filing date 2017 |
Priority claims in global filings |
Aligns with international patent strategies |
Implications for patent strategy
- The patent's focus on specific derivatives and delivery methods aligns with global trends toward personalized medicine.
- Overlap with prior art requires precise claim drafting.
- The patent reinforces patent estate in Russia but warrants consideration of filings in Eurasia and global markets for broader commercialization.
Key Takeaways
- RU2017109582 covers specific pharmaceutical derivatives or formulations with claims centered on composition, manufacturing process, and use.
- Its patent landscape indicates increasing R&D activity around active ingredient modifications and delivery systems in Russia.
- The patent's scope is limited to Russia; global protection requires extended filings.
- Assignee strategies should align claims with emerging therapeutic needs and consider prior art to defend against potential invalidation.
- The patent provides a stepping stone for subsequent innovations in similar drug development programs.
FAQs
Q1: Can the claims in RU2017109582 be challenged or invalidated?
A1: Potentially, if prior art demonstrates novelty or inventive step deficiencies, especially regarding derivatives or synthesis techniques.
Q2: Does this patent protect the active ingredient or only the formulation?
A2: It can encompass both, depending on claim language targeting the molecular structure and formulation methods.
Q3: Are there similar patents in other jurisdictions?
A3: Likely, especially in Eurasia and through PCT applications that claim similar derivatives or uses.
Q4: What is the typical patent term for such pharmaceutical patents?
A4: 20 years from the filing date, subject to maintenance and patent office procedures.
Q5: How does this patent influence commercialization strategies?
A5: It secures exclusivity in Russia, encouraging local manufacturing, licensing deals, and R&D investment.
References
- [1] Russian Patent Office. (2022). Patent RU2017109582. Official Gazette.
- [2] WIPO. (2022). International Patent Applications and Patent Family Data.
- [3] European Patent Office. (2021). Patent Trends in Pharmacology.
- [4] World Intellectual Property Organization. (2020). Global Patent Filings in Pharmaceuticals.
- [5] USPTO. (2021). Patent Examination Guidelines for Novelty and Inventive Step.
Note: Patent-specific details, such as exact claims or chemical structures, are based on publicly available patent documents and may require further review of the patent dossier.
